NUTRA PHARMA CORP
AI Executive Summary
AI-powered analysis of 10-Q filing content
Nutra Pharma Corp exhibits severe financial distress with stockholders' deficit of $16.2M worsening from $14.8M, current liabilities of $16.8M vastly exceeding current assets of $552K, and critical cash decline to just $13,843. The company faces imminent liquidity crisis with derivative liabilities more than doubling to $1.67M.
Red Flags Detected (6)
Current liabilities ($16.8M) exceed current assets ($552K) by over 30:1 ratio
Cash decreased 62% to critically low $13,843
Stockholders' deficit worsened by $1.4M to negative $16.2M
3 more red flags detected
Key Takeaways
Company faces immediate going concern issues with extreme working capital deficit
Derivative liability explosion suggests equity dilution or debt conversion pressures
2 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.